The role of oxidative stress in physiological and pathological processes in the thyroid gland; possible involvement in pineal-thyroid interactions

Neuroendocrinology Letters

Volumn 24, Issue 5, 2003, Pages 293-303

  Karbownik, Malgorzata ^a,b   Lewinski, Andrzej ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Antioxidant; Melatonin; Oxidative damage; Thyroid gland; Thyroid hormones

Indexed keywords

ANTIOXIDANT; FREE RADICAL; GLUTATHIONE; HYDROGEN PEROXIDE; IODIDE; IODINE 131; LIOTHYRONINE; MELATONIN; PROPYLTHIOURACIL; REACTIVE OXYGEN METABOLITE; SCAVENGER; THIAMAZOLE; THYROID HORMONE; THYROXINE;

GOITER; GRAVES DISEASE; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MEDICAL RESEARCH; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PINEAL BODY; RAT; REVIEW; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE SYNTHESIS; THYROIDECTOMY;

EID: 0242637261     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82:47-95.
2. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A:30-8.
3. Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med 2002; 32:833-40.
4. Zimmermann M, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid 2002; 12:867-78.
5. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S. Mayo JC, Sainz RM, Reiter RJ. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-8.
6. Kvetnoy IM. Extrapineal melatonin in pathology: new perspectives for diagnosis, prognosis, and treatment of illness. Neuroendocrinol Lett 2002; 23(Suppl 1):92-6.
7. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
8. Reiter RJ. Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol 1998; 56:359-84.
9. Reiter RJ, Tan D-X, Allegra M. Melatonin: reducing molecular pathology and dysfunction due to free radical and associated reactants. Neuroendocrinol Lett 2002; 23(Suppl. 1):3-8.
10. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000; 9:160-71.
11. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Limson J, Weintraub ST, Qi W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000; 29:1177-85.
12. Hardeland R, Poeggeler B, Niebergall R, Zelosko V. Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 2003; 34: 17-25.
13. Karbownik M, Gitto E, Lewinski A, Reiter RJ. Relative efficacies of indole antioxidants in reducing autoxidation and iron-induced lipid peroxidation in testes: implications for cancer initiation. J Cell Biochem 2001: 81:693-9.
14. Karbownik M, Reiter RJ, Burkhardt S, Gitto E, Tan D-X, Lewinski A. Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention. Exp Biol Med 2001; 226:707-12.
15. Karbownik M, Gitto E, Lewinski A, Reiter RJ. Induction of lipid peroxidation in hamster organs by the carcinogen cadmium: Amelioration by melatonin. Cell Biol Toxicol 2001; 17:33-40.
16. Karbownik M, Reiter RJ. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225:9-22.
17. Karbownik M, Lewinski A, Reiter RJ. Anticarcinogenic actions of melatonin which involve antioxidative processes: Comparison with other antioxidants. Int J Biochem Cell Biol 2001; 33: 735-53.
18. Karbownik M, Reiter RJ. Melatonin protects against oxidative stress caused by δ-aminolevulinic acid: Implication for cancer reduction, Cancer Invest 2002; 20:276-86.
19. Lewinski A, Vaughan MK, Champney TH, Reiter RJ, Smith NKR. Dark exposure inhibits the mitotic activity of thyroid follicular cells in male mice with intact pineal. Experientia 1984; 40: 1284-5.
20. Lewinski A, Sewerynek E. Melatonin inhibits the basal and TSH-stimutated mitotic activity of thyroid follicular cells in vivo and in organ culture. J Pineal Res 1986; 3:291-9.
21. Wajs E, Krotewicz M, Fryczak J, Kulak J, Sewerynek E, Szkudlinski M, et al, Melatonin suppresses the pinealectomy-induced increase of mitotic incidence in the rat thyroid gland. Med Sci Res 1989; 17:61-2.
22. Wajs E, Lewinski A. Inhibitory influence of late-afternoon melatonin injections and the counter-inhibitory effect of melatonin pellets on thyroid growth processes in male Wistar rats; comparison with effects of other indole substances. J Pineal Res 1992; 13:158-66.
23. Lewinski A, Wajs E, Krotewicz M. Melatonin and other indolic substances: their influence on thyroid growth and secretion. In: Touitou Y Arendt J Pevet P, editors. Melatonin and the Pineal Gland - From Basic Science to Clinical Application. Amsterdam: Excerpta Medica; 1993. pp. 265-8.
24. Lewinski A, Wajs E, Modrzejewska H, Klencki M, Karbownik M, Greger J. Inhibitory influence of melatonin on thymidine kinase activity in the rat thyroid lobes incubated in vitro. Neuroendocrinol Lett 1994; 16:221-6.
25. Krotewicz M, Lewinski A, Wajs E. The inhibitory effect of late afternoon melatonin injections, but not of melatonin-containing subcutaneous implants, on thyroid hormone secretion in male Wistar rats. Neuroendocrinol Lett 1992; 14:405-11.
26. Krotewicz M, Lewinski A. Effects of pinealectomy and of late afternoon injections of pineal indole substances on thyroid hormone secretion in male Wistar rats. Biochem Lett 1994; 50:101-7.
27. Wright ML, Cuthbert KL, Donohue MJ, Solano SD, Proctor KL. Direct influence of melatonin on the thyroid and comparison with prolactin. J Exp Zool 2000; 286:625-31.
28. Lewinski A. Some aspects of the pineal-thyroid interrelationship and their possible involvement in the regulation of function and growth of these two glands. In: Reiter RJ, Lukaszyk A, editors. Advances in Pineal Research. Vol. IV. London: John Libbey and Company Ltd.; 1990. p. 175-88.
29. Lewinski A, Wajs E, Klencki M, Krotewicz M, Bilinski P. Melatonin-induced inhibition of thyroid growth processes and possible mechanisms of that phenomenon. In: Haldar C, editor. Recent Researches in Biology, vol. 1: The Pineal Gland: Its Molecular Signals. New Delhi: Hindustan Publishing Corporation; 1996. pp. 27-32.
30. Lewinski A, E. Wajs, M. Klencki, M Karbownik, A Gesing, E Sewerynek, D Slowinska-Klencka, E Skowronska-Józwiak, P Bilinski and M Krotewicz. Pineal-thyroid interrelationships update: 1996. In: SM Webb, M Puig-Domingo, M Moller, E Pevet, editors. Pineal Update from Molecular Mechanisms to Clinical Implications. Westbury, NY: PJD Publications Limited; 1997. pp. 173-81.
31. Lewinski A, Karbownik M. Melatonin and the thyroid gland. Neuroendocrinol Lett 2002; 23 (suppl 1):73-78.
32. Lewinski A, Sewerynek E, Karbownik M. Melatonin from the Past into the future - Our Own Experience. In: Haldar C, Singaravel M, Maitra SK, editors. Treatise on Pineal Gland and Melatonin. Enfield (NH), USA, and Plymouth, UK: Science Publishers, Inc.; 2002. p. 157-75.
33. 2 in isolated porcine thyroid follicles. Endocrinology 1984; 115:392-398.
34. 2 generation and I-uptake by thyrotropin through the cyclic adenosine 3′,5′-monophasphate cascade. Endocrinology 1995; 135:965-973.
35. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase: cloning of the porcine and human cDNAs. J Biol Chem 1999; 274:37265-9.
36. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 2000; 275:23227-33.
37. Nunez J, Pommier J. Formation of thyroid hormones. Vitam Horm 1982; 39:175-229
38. 2 generated at the apical surface of thyroid cells in autocatalytic covalent heme binding. J Biol Chem 1999; 274: 10533-8.
39. Nakamura Y, Ohtaki S, Makino R, Tanaka T, Ishimura Y. Superoxide anion is the initial product in the hydrogen peroxide formation catalyzed by NADPH oxidase in porcine thyroid plasma membrane. J Biol Chem 1989: 264:4759-61.
40. 2 generating machinery. Biochemistry 1991; 30: 4880-6.
41. Sugawara M, Sugawara Y, Wen K, Giulivi C. Generation of oxygen free radicals in thyroid cells and inhibition of thyroid peroxidase. Exp Biol Med 2002; 227:141-6.
42. Lindsay RH, Gaitan E, Cooksey RC. Pharmacokinetics and intrathyroidal effects of flavonoids. In: Environmental Goitro-genesis, Gaitan E, editor. Boca Raton, Fl: CRC Press; 1989. pp. 43-56.
43. Ferreira AC, Rosenthal D, Carvalho DP. Thyroid peroxidase inhibition by Kalanchoe brasiliensis aqueous extract. Food Chem Toxicol 2000; 38:417-21.
44. 2 generation. Biochem Biophys Res Commun 1988; 154:1287-92.
45. 2 induces apoptosis of pig thyrocytes in culture. J Endocrinol 1998; 156:315-22.
46. Vitale M, Di Matola T, D'Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G. Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 2000; 141:598-605.
47. Esteves RZ, van Sande J, Dumont JE. Nitric oxide as a signal in thyroid. Mol Cell Endocrinol 1992; 90:R1-3.
48. Millatt LJ, Jackson R, Williams BC, Whitley GStJ. Nitric oxide stimulates cyclic GMP in human thyrocytes. J Mol Endocrinol 1993; 10:163-69.
49. Colin IM, Nava E, Toussaint D, Maiter DM, VanDenhove MF, Luscher TF, Ketelslegers JM, Denef JF, Jameson JL. Expression of nitric oxide synthase isoforms in the thyroid gland: evidence for a role of nitric oxide in vasculatur control during goiter formation. Endocrinology 1995; 136:5283-90.
50. Bocanera LV, Krawiec L, Silberschmidt D, Pignatoro O, Juvenal GJ, Pregliasco LB, Pisarev MA. Rote of cyclic 3′5′guanosine monophosphate and nitric oxide in the regulation of iodide uptake in calf thyroid cells. J Endocrinol 1997; 155:451-7.
51. Millatt LJ, Johnstone AP, Whitley GS. Nitric oxide enhances thyroid peroxidase activity in primary human thyrocytes. Life Sci 1998; 63:PL373-80.
52. Motohashi S, Kasai K, Banba N, Hattori Y, Shimoda S. Nitric oxide inhibits cell growth in cultured human thyrocytes. Life Sci 1996; 59:PL227-34.
53. Noda Y, Mori A, Liburdy R, Packer L. Melatonin and its precursors scavenge nitric oxide. J Pineal Res 1999; 27:159-63.
54. Gilad E, Cuzzocrea S, Zingarelli B, Salzman AL, Szabo C. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60: PL169-74.
55. Brömme H-J, Ebelt H, Peschke D, Peschke E. Alloxan acts as a prooxidant only under reducing conditions: influence of melatonin. Cell Mol Life Sci 1999; 55:487-93.
56. Taurog A, Dorris M, Doerge DR. Evidence for a radical mechanism in peroxidase-catalyzed coupling. I. Steady-state experiments with various peroxidases. Arch Biochem Biophys 1994; 315:82-9.
57. Doerge DR, Taurog A, Dorris ML. Evidence for a radical mechanism in peroxidase-catalyzed coupling. II. Single turnover experiments with horseradish peroxidase. Arch Biochem Biophys 1994; 315:90-9.
58. Taurog A, Dorris ML, Doerge DR. Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. Arch Biochem Biophys 1996; 330:24-32.
59. Gmeiner BMK, Seelos CCC. Tyrosine phosphorylation blocks tyrosine free radical formation and, hence, the hormonogenic iodination reaction. Free Radic Biol Med 1996; 21:349-51.
60. Taurog A. Hormone synthesis. In: Braverman LE, Utiger RD, editors. Werner's and Ingbar's The Thyroid. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 52-90.
61. Delom F, Lejeune P-J, Vinet L, Carayon P, Mallet B. Involvement of oxidative reactions and extracellular protein chaperons in the rescue of misassembled thyroglobulin in the follicular lumen. Biochem Biophys Res Commun 1999; 255:438-43.
62. Pomerance M, Abdullah H-B, Kamerji S, Correze C, Blondeau J-P. Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, Rac1, and reactive oxygen species. J Biol Chem 2000; 275:40539-46.
63. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. J Biol Chem 1998; 273:15022-9.
64. Browning DD, Windes ND, Ye RD. J Biol Chem 1999; 274: 537-42.
65. Sugawara M, Kita T, Lee ED, Takamatsu J, Hagen GA, Kuma K, Medeiros-Neto GA. Deficiency of thyroid superoxide dismutase in endemic goiter tissue. J Clin Endocrinol Metab 1988; 67: 1156-61.
66. Cadet J, Delatour T, Douki T, Gasparutto D, Pouget JP, Ravanat JL, Sauvaigo S. Mutat Res 1999; 424:9-21
67. Sadani GR, Nadkarni GD. Rote of tissue antioxidant defence in thyroid cancers. Cancer Lett 1996; 109:231-5.
68. Rhee SG. Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 1999; 31:53-9.
69. Mano T, Iwase K, Hayashi R, Hayakawa N, Uchimura K, Makino M, Nagata M, Sawai Y, Oda N, Hamada M, Aono T, Nakai A, Nagasaka A, Itoh M. Vitamin E and coenzyme Q concentrations in the thyroid tissues of patients with various thyroid disorders. Am J Med Sci 1998; 315:230-2.
70. Nakamura M, Ohtaki S. Formation and reduction of ascorbate radicals by hog thyroid microsomes. Arch Biochem Biophys 1993; 305:84-90.
71. Kim H, Lee T-H, Park ES, Suh JM, Park SJ, Chung HK, Kwon O-Y, Kim YK, Ro HK, Shong M. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 2000; 275: 18266-70.
72. Kvetnoy IM. Extrapineal melatonin: location and rote within diffuse neuroendocrine system. Histochem J 1999; 32:1-12.
73. Iwase K, Nagasaka A, Kato K, Ohtani S, Tsujimura T, Inagaki A, Jimbo S, Nakai QA, Masunaga R, Hamada M, Mano T, Kotake M, Miura K. Localization of Cu/Zn and Mn superoxide dismutase in various thyroid disorders. Acta Endocrinol (Copen) 1993; 129: 573-8.
74. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimura K, Hayakawa N, Hayashi R, Nakai A, Ishizuki Y, Nagasaka A. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 1997; 29: 351-4.
75. Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H, Yoshida H. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett 1999; 145:127-32
76. Kitano H, Kitanishi T, Nakanishi Y, Suzuki M, Taleuchi E, Yazawa Y, Kitajima K, Kimura H, Tooyama I. Expression of inducible nitric oxide synthase in human thyroid papillary carcinoma. Thyroid 1999; 9:113-7.
77. Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N. Decreased expression of catalase mRNA in thyroid anaplastic carcinoma. Jpn J Clin Oncol 2003; 33:6-9.
78. Karbownik M, Zasada K, Zygmunt A, Brzezianska E, Lewinski A. Melatonin reduces iron-induced Lipid peroxidation in porcine thyroid. 6th European Congress of Endocrinology, 26-30 April 2003, Lyon, France, P0180.
79. Mutaku JF, Many MC, Colin I, Denef JF, van den Hove MF. Antigoitrogenic effect of combined supplementation with dl-alpha-tocopherol, ascorbic acid and beta-carotene and of dl-alpha-tocopherol alone in the rat. J Endocrinol 1998; 156: 551-61.
80. Mutaku JF, Poma JF, Many MC, Denef JF, Van Den Hove MF. Cell necrosis and apoptosis are differentially regulated during goitre development and iodine-induced involution. J Endocrinol 2002; 172:375-86.
81. Giray B, Hincal F, Tezic T, Okten A, Gedik Y. Status of selenium and antioxidant enzymes of goitrous children is lower than healthy controls and nongoitrous children with high iodine deficiency. Biol Trace Elem Res 2001; 82:35-52.
82. Giray B, Hincal F. Oxidative DNA base damage, antioxidant enzyme activities and selenium status in highly iodine-deficient goitrous children. Free Radic Res 2002; 36:55-62.
83. Karasek M, Stankiewicz A, bandurskaankiewicz E, Zylinska K, Pawlikowski M, Kuzdak K. Melatonin concentrations in patients with large goiter before and after surgery. Neuroendocrinol Lett 2000; 21:437-9.
84. Duthoit C, Estienne V, Delom F, Durand-Gorde J-M, Mallet B, Carayon P, Ruf J. Production of immunoreactive thyroglobulin C-terminal fragments during thyroid hormone synthesis. Endocrinology 2000; 141:2518-25.
85. Duthoit C, Estienne V, Giraud A, Durand-Gorde J-M, Rasmussen AK, Feldt-Rasmussen U, Carayon P, Ruf J. Hydrogen peroxide-induced production of a 40 kDa immunoreactive thyroglobulin fragment in human thyroid cells; the onset of thyroid autoimmunity. Biochem J 2001; 360:557-62.
86. Van den Hove M-F, Stenoiu MS, Croizet K, Couvreur M, Courtoy PJ, Devuyst O, Colin IM. Nitric oxide is involved in interleukin-1α -induced cytotoxicity in polarised human thyrocytes. J Endocrinol 2002; 173:177-85.
87. Lu R, Wang P, Wartofsky L, Sutton BD, Zweier JL, Bahn RS, Garrity J, Burman KD. Oxygen free radicals in interleukin-a1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients. Thyroid 1999; 9:297-303.
88. Guerrero JM, Reiter RJ. Melatonin-immune system relationship. Curr Top Med Chem 2002; 2:167-79.
89. Lewinski A, Zelazowski P, Sewerynek E, Zerek-Melen G, Szkudlinski M, Zelazowska E. Melatonin-induced suppression of human lymphocyte natural killer activity in vitro. J Pineal Res 1989; 7:153-64.
90. Goglia F, Silvestri E, Lanni A. Thyroid hormones and mitochondria. Biosci Rep 2002; 22:17-32.
91. Hanna AN, Feller DR, Witiak DT, Newman HAI. Inhibition of low density lipoprotein oxidation by thyronines and probucol. Biochem Pharmacol 1993; 45:753-62.
92. Chomard P, Seguin C, Loireau A, Autissier N, Artur Y. Effects of iodotyrosines, thyronines, iodothyroacetic acids and thyromimetic analogues on in vitro copper-induced oxidation of low-density lipoproteins. Biochem Pharmacol 1998; 55: 1591-601.
93. Oziol L, Faure P, Vergely C, Rochette L, Artur Y, Chomard P. In vitro free radical scavenging capacity of thyroid hormones and structural analogues. J Endocrinol 2001; 170:197-206.
94. Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A. Free radical activity and antioxidant defense mechanism in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000; 300: 107-17.
95. Sewerynek E, Wiktorska J, Nowak D, Lewinski A. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves' disease. Endocrine Regul 2000; 34:83-9.
96. Hara H, Sato R, Ban Y. Production of 8-OHdG and cytochrome C by cultured human mononuclear cells in patients with autoimmune thyroid disease. Endocr J 2001; 48:671-5.
97. Fernandez V, Videla LA. Influence of hyperthyroidism on superoxide radical and hydrogen peroxide production by rat liver submitochondrial particles. Free Radic Res Commun 1993; 18:329-35.
98. Fernandez V, Cornejo P, Tapia G, Videla LA. Influence of hyperthyroidism on the activity of liver nitric oxide synthase in the rat. Nitric Oxide 1997; 1:463-8.
99. Tapia G, Cornejo P, Fernandez V, Videla LA. Protein oxidation in thyroid hormone-induced liver oxidative stress: relation to lipid peroxidation. Toxicol Lett 1999; 106:209-14.
100. Venditti P, Balestrieri M, Di Meo S, De Leo T. Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues. J Endocrinol 1997; 155:151-57.
101. Gredilla R, Barja G, Lopez-Torres M. Thyroid hormone-induced oxidative damage on lipids, glutathione and DNA in the mouse heart. Free Radic Res 2001; 35:417-25.
102. Gredilla R, Torres ML, Portero-Otin M, Pamplona R, Barja G. Influence of hyper- and hypothyroidism on lipid peroxidation, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondrial DNA in mice skeletal muscle. Mol Cell Biochem 2001; 221:41-8.
103. Sewerynek E, Wiktorska J, Lewinski A. Effects of melatonin on the oxidative stress induced by thyrotoxicosis in rats. Neuroendocrinol Lett 1999; 20:157-61.
104. Swaroop A, Ramasarma T. Heat exposure and hypothyroid conditions decrease hydrogen peroxide generation in liver mitochondria. Biochem J 1985; 226:403-8.
105. Paller MS. Hypothyroidism protects against free radical damage in ischemic acute renal failure. Kidney Int 1986; 29: 1162-6.
106. Hicks M, Wong LS, Day RO. Antioxidant activity of propylthiouracil. Biochem Pharmacol 1992; 43:439-44.
107. Ross AD, Dey I, Janes N, Israel Y. Effect of antithyroid drugs on hydroxyl radical formation and α-1-proteinase inhibitor inactivation by neutrophils: therapeutic implications. J Pharmacol Exp Ther 1998; 285:1233-8.
108. Rahaman SO, Ghosh S, Mohanakumar KP, Das S, Sarkar PK. Hypothyroidism in the developing rat brain is associated with marked oxidative stress and aberrant intraneuronal accumulation of neurofilaments. Neurosci Res 2001; 40:273-9.
109. Bellipanni G, Bianchi P, Pierpaoli W, Bulian D, Ilyia E. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol 2001; 36:297-310.
110. Siegrist C, Benedetti C, Orlando A, Beltran JM, Tuchscherr L, Noseda CM, et al. Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients. J Pineal Res 2001; 30:34-42.
111. Konukoglu D, Hatemi HH, Arikan S, Demir M, Akcay T. Radioiodine treatment and oxidative stress in thyroidectomised patients for differentiated thyroid cancers. Pharmacol Res 1998; 38:311-5.
112. Wolfram RM, Budinsky AC, Palumbo B, Palumbo R, Sinzinger H. Radioiodine therapy induces dose-dependent in vivo oxidation injury: evidence by increased isoprostane 8-epi-PGF(2 alpha). J Nucl Med 2002; 43:1254-8.
113. Kundurovic Z, Scepovic M. Histoenzymological reactions of the thyroid gland in irradiated and previously melatonin-treated irradiated rats. Acta Med Iugosl 1989; 43:337-47.
114. Kundurovic Z, Mornjakovic Z. Morphometric characteristics of thyroid cells in irradiation stressed rats treated with pinealectomy and melatonin. [In Serbo-Croatian (Roman)]. Med Arh 1992; 46:9-10.